Get 20% lifetime commission for referring investors to digrin.com
here.
CAMP4 Therapeutics Corporation ( CAMP) - Key Metrics
CAMP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.03 | -$0.58 | -$0.22 | -$0.22 |
| 2026Q1 | $0.02 | -$0.32 | -$0.19 | -$0.19 |
| 2025Q4 | $0.01 | -$0.78 | $0.12 | $0.12 |
| 2025Q3 | $0.04 | -$0.75 | -$0.56 | -$0.56 |
| 2025Q2 | $0.07 | -$0.62 | -$0.51 | -$0.51 |
CAMP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.88 |
| 2026Q1 | 0% | -3.45 |
| 2025Q4 | 0% | -1.96 |
| 2025Q3 | 0% | -1.36 |
| 2025Q2 | 0% | -0.58 |
CAMP
Price: $5
52 week price:
Earnings Per Share: -2.35 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 144300
Ebitda: 23.8 millionMarket Capitalization: 341.4 million